Facebook
Twitter
LinkedIn
Forward
Intermittent Fasting (IF) as a means of dietary modification has gained popularity among individuals with obesity as a means of achieving weight loss.
|
Individual patient response to nutritional therapies varies widely.
|
Recent AAP obesity guidelines point out that "watchful waiting" can delay treatment.
|
This presentation discusses the particular administrative needs and challenges related to treating obesity.
|
This session utilizes a direct instructional format to expand on the recent American Academy of Pediatrics Clinical Practice Guidelines for the Evaluation and Treatment of Children and Adolescents
|
Metabolic/Bariatric Surgery is well-known for the impressive weight loss.
|
This session covers new AASLD guidelines for screening, disease associations, diagnosis, and treatments.CME/CE Expiration Date: 10/27/26
|
This session will inform HCPs on the tirzepatide molecule, design of the SURMOUNT global trial program for the treatment of obesity and overweight, and safety and efficacy data disclosure for SURMO
|
Registration is limited to 140 attendees, so don't wait to sign up! Registration will close once the limit is reached.
|
Registration is limited to 140 attendees, so don't wait to sign up! Registration will close once the limit is reached.
|